The detrimental course of acute intestinal ischemia: improvement of the diagnosis

The detrimental course of acute intestinal ischemia: improvement of the diagnosis - TACTIC trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52596

Enrollment

100

Registered

2019-09-04

Start date

2020-09-18

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel ischemia Mesenteric Ischemia

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: The following inclusion criteria will be used: Age >= 18 years All consecutive patients admitted to one of the participating medical centers emergency departments (ED) or at the intensive care unit (ICU) (see 4.1 Population Base) with clinical suspicion of acute intestinal ischemia, which is based on; o clinical manifestation; o physical examination by the physician; o laboratory measurements; o physician*s consideration to perform computed tomography (CT)-scan

Exclusion criteria

Exclusion criteria: Younger than 18 years of age

Design outcomes

Primary

Measure	Time frame
The primary endpoint of the study is the early and accurate identification of presence and severity of acute intestinal ischemia in patients. The main study parameters are plasma biomarkers indicative for intestinal damage of patients suspected of acute intestinal ischemia.	—

Secondary

Measure	Time frame
The secundary study paramater is the identfication of volatile organic compounds (VOC) in exhaled air of patients suspected of acute intestinal ischemia.	—

Countries

Netherlands

Outcome results